The DOI matches its Crossref record; 133 of the 135 references it cites were found in a registry or an index.
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
Open accessAbstract
The incidence and prevalence of diabetes mellitus (DM) continue to grow dramatically throughout the world, due primarily to the increase in type 2 DM (T2DM). Although improvements in DM and hypertension management have reduced the proportion of diabetic individuals who develop chronic kidney disease (CKD) and progress to end-stage renal disease (ESRD), the sheer increase in people developing DM will have a major impact on dialysis and transplant needs. This KDIGO conference addressed a number of controversial areas in the management of DM patients with CKD, including aspects of screening for CKD with measurements of albuminuria and estimated glomerular filtration rate (eGFR); defining treatment outcomes; glycemic management in both those developing CKD and those with ESRD; hypertension goals and management, including blockers of the renin-angiotensin-aldosterone system; and lipid management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The absence of effect modification by baseline albuminuria contrasts with the findings from trials of RAS blockade.[31][32][33]”
From SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis (2019) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetes management may be particularly challenging in individuals with chronic kidney disease who may be at an increased risk of hypoglycemia and in whom HbA 1c can be falsely low (276)”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [276]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Research works printed but not linked: 1
- Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group, 2013, KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease, Kindey Int Suppl, 3, 259
Cited by
Sorted by citations
Items 101–200 of 268
Zhou, L., Lv, L., Qiu, S., Yin, Q., Li, Z., Tang, T., Ni, L., Ye, F., Wang, B., Ma, K., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1818-2 · Cited by 21
Zafari, N., Churilov, L. P., MacIsaac, R. J., Torkamani, N., Baxter, H., Kiburg, K., & Ekinci, E. I. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031558 · Cited by 21
Ni, Y., Yang, W., Wang, S., Pan, Y., Du, H., Zheng, L., Cai, C., Fu, Z., He, Q., Jin, J., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156677 · Cited by 20
Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine
Tuot, D. S., Lin, F., Shlipak, M. G., Grubbs, V., Hsu, C., Yee, J., Shahinian, V. B., Saran, R., Saydah, S., Williams, D. E., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0542 · Cited by 20
Chang, T., Chiang, C., Chen, C., Lin, S.-C., Lee, H.-J., & Chen, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113139 · Cited by 20
Association of Hypoglycemia With Incident Chronic Kidney Disease in Patients With Type 2 Diabetes
Shih, C.-J., Wu, Y.-L., Lo, Y., Kuo, S., Tarng, D., Lin, C., Ou, S., & Chen, Y. (2015) · Medicine · doi:10.1097/md.0000000000000771 · Cited by 20
Adverse safety events in patients with Chronic Kidney Disease (CKD)
Offurum, A. I., Wagner, L.-A., & Gooden, T. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1236909 · Cited by 21
Wakisaka, M., Kamouchi, M., & Kitazono, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225668 · Cited by 19
Uzu, T., Araki, S.-I., Kashiwagi, A., Haneda, M., Koya, D., Yokoyama, H., Kida, Y., Ikebuchi, M., Nakamura, T., Nishimura, M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164936 · Cited by 18
Yu, B., Huang, C., Fan, X.-F., Li, F., Zhang, J., Song, Z., Zhi, N., & Ding, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.846407 · Cited by 18
Noninvasive Assessment of Diabetic Kidney Disease With MRI : Hype or Hope?
Zhao, K., Seeliger, E., Niendorf, T., & Liu, Z. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29000 · Cited by 18
Huang, R., Feng, Y., Wang, Y., Qin, X., Melgiri, N. D., Sun, Y., & Li, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168582 · Cited by 18
Effects of Folic Acid Therapy on the New-Onset Proteinuria in Chinese Hypertensive Patients
Li, Y., Liang, M., Wang, G., Wang, B., He, M., Tang, G., Yin, D., Xu, X. P., Huo, Y., Cui, Y., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09404 · Cited by 18
Cissus quadrangularis extract attenuates diabetic nephropathy by altering SIRT1/DNMT1 axis
Syed, A. A., Reza, M. I., Garg, R., Goand, U. K., & Gayen, J. R. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab078 · Cited by 18
Mohammadi‐Shemirani, P., Sjaarda, J., Gerstein, H. C., Treleaven, D. J., Walsh, M. W., Mann, J. F. E., McQueen, M., Hess, S., & Paré, G. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.291104 · Cited by 18
Marzolla, V., Infante, M., Armani, A., Rizzo, M., & Caprio, M. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2130889 · Cited by 19
Current therapeutic approaches in the management of hyperglycemia in chronic renal disease
Garla, V. V., Yanes-Cardozo, L. L., & Lien, L. F. (2017) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9416-1 · Cited by 17
FITCHETT, D. H. (2018) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2018.14.2.40 · Cited by 19
Long-term complications of type 1 diabetes: what do we know and what do we need to understand?
Piona, C. A., VENTRICI, C., MARCOVECCHIO, L., CHIARELLI, F., MAFFEIS, C., Bonfanti, R., & Rabbone, I. (2021) · Minerva Pediatrics · doi:10.23736/s2724-5276.21.06545-9 · Cited by 19
Value of radiomics-based two-dimensional ultrasound for diagnosing early diabetic nephropathy
Su, X., Shu, L., & Huang, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-47449-2 · Cited by 17
Lee, E., & Lee, H. S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26875 · Cited by 16
Voroneanu, L. E., Siriopol, D. C., Dumea, R., Bădărau, S., Kanbay, M., Afşar, B., Gavrilovici, C., & Covic, A. C. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1697-5 · Cited by 16
Yaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117916 · Cited by 15
Moradi, M., Daneshzad, E., Najafabadi, M. M., Bellissimo, N., Suitor, K., & Azadbakht, L. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.09.032 · Cited by 16
Cuţaş, A., Drugan, C., Román, G., Rusu, A., Cătană, C.-S., Achimaş-Cadariu, A., & Drugan, T. (2021) · Diagnostics · doi:10.3390/diagnostics11020263 · Cited by 15
Gao, Z., Zhu, Y., Sun, X., Zhu, H., Jiang, W., Sun, M., Wang, J., Le, L., Zheng, H., Qin, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064665 · Cited by 15
Combining incretin-based drugs and RAAS inhibitors: more cons than pros?
Tonneijck, L., Muskiet, M. H. A., Smits, M. M., van Raalte, D. H., & Diamant, M. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70167-6 · Cited by 14
Diabetische Nierenerkrankung (Update 2026)
Sourij, H., Aberer, F., Antlanger, M., Brix, J., Cejka, D., Clodi, M., Edlinger, R., Eller, K., Horn, S., Kaser, S., et al. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-0992-y · Cited by 14
pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression
Chevallier, E., Jouvé, T., Rostaing, L. P. E., Malvezzi, P., & Noble, J. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1851596 · Cited by 13
Bouchi, R., Ohara, N., Asakawa, M., Nakano, Y., Takeuchi, T., Murakami, M., Sasahara, Y., Numasawa, M., Minami, I., Izumiyama, H., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0335-3 · Cited by 14
Managing the Course of Kidney Disease in Adults With Type 2 Diabetes: From the Old to the New
Goldenberg, R., Berall, M. J., Chan, C. T., Cherney, D. Z. I., Lovshin, J. A., McFarlane, P. A., Senior, P. A., Verma, S., & Weinstein, J. J. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.06.008 · Cited by 15
Oellgaard, J., Gæde, P., Persson, F., Rossing, P. R., Parving, H., & Pedersen, O. B. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.09.012 · Cited by 14
Reversal of hypertriglyceridemia in diabetic BTBR ob/ob mice does not prevent nephropathy
Attie, A., Schueler, K., Keller, M. P., Mitok, K. A., Simonett, S. P., Hudkins, K. L., Mehrotra, K., Graham, M. J., Lee, R. G., & Alpers, C. E. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00592-8 · Cited by 14
de Sá, J. R., Rangel, É. B., Canani, L. H. S., Bauer, A. C., Escott, G. M., Zelmanovitz, T., Bertoluci, M. C., & Silveiro, S. P. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00843-8 · Cited by 16
Yang, J., Xiong, X. ‐., Xiao, Y., Wei, L., Li, L., Yang, M., Han, Y., Zhao, H., Li, C. ‐., Jiang, N., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14364 · Cited by 13
Hayfron-Benjamin, C. F., der Zee, A. H. M., van den Born, B. H., Amoah, A. G. B., Meeks, K. A. C., Klipstein‐Grobusch, K., Schulze, M. B., Spranger, J., Danquah, I., Smeeth, L. L., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001235 · Cited by 13
Qiu, S., Xie, D., Guo, S., Wang, Z., Cai, Y., Xian, W. A. N. G., Hu, Z., Wang, S., Lin, C., Yao, H., et al. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02990-7 · Cited by 12
Ma, Q., Hu, X., Liu, F., Cao, Z., Han, L., Zhou, K., Bai, Y., Zhang, Y., Nan, Y., Lv, Q., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1011442 · Cited by 12
Hussain, A., Culliford, A., Phagura, N., Evison, F., Gallier, S., & Sharif, A. (2021) · Diabetic Medicine · doi:10.1111/dme.14707 · Cited by 12
Pharmacological Management of Diabetic Nephropathy
Papademetriou, V., Alataki, S., Stavropoulos, K., Papadopoulos, C. E., Bakogiannis, K., & Tsioufis, K. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190405164749 · Cited by 12
Diabetes is a risk factor for high-dose methotrexate-associated AKI in lymphoma patients
Wang, Y., Wei, L., Guan, Y., Wang, Q., Xie, Q., & Hao, C. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1838926 · Cited by 12
Sun, Z., Wang, K., Miller, J. D., Yuan, X., Lee, Y., & Lou, Q. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059139 · Cited by 11
Preventing the development and progression of diabetic kidney disease: Where do we stand?
Zagkotsis, G., Markou, M. I., Paschou, E., Papanikolaou, P., & Sabanis, N. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.012 · Cited by 12
REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease
Wang, X., Wu, H., Yang, G., Xiang, J., Xiong, L., Zhao, L., Liao, T., Zhao, X., Kang, L., Yang, S., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.935796 · Cited by 11
Shih, C.-J., Chu, H., Ou, S., & Chen, Y. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.07.053 · Cited by 11
Zimbudzi, E., Lo, C., Misso, M. L., Ranasinha, S., & Zoungas, S. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0072-9 · Cited by 11
Hutton, H., Alikhan, M. A., & Kitching, A. R. (2018) · Experientia supplementum · doi:10.1007/978-3-319-89390-7_8 · Cited by 11
Zhao, D., Guo, J., Liu, L., & Huang, Y. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej20-0783 · Cited by 11
Shigidi, M. M. T., & Karrar, W. N. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102320 · Cited by 10
Duan, S., Geng, L., Fang, L., Chen, C., Jiang, L., Chen, S., Zhang, C., Huang, Z., Zeng, M., Sun, B., et al. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.102963 · Cited by 10
New perspectives in the management of diabetic nephropathy
Psyllaki, A., & Τζιόμαλος, Κ. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i6.1086 · Cited by 10
Effects of PPARs/20-HETE on the renal impairment under diabetic conditions
Ding, S., Huang, J., Qiu, H., Chen, R., Zhang, J., Huang, B., Cheng, O., & Jiang, Q. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.05.036 · Cited by 10
Considerations and controversies in managing chronic kidney disease: An update
Prasad‐Reddy, L., Isaacs, D. M., & Kantorovich, A. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160559 · Cited by 10
Liu, Y., Liu, L., Yi, B., Hu, Z., Li, A., Yang, C., Zheng, L., & Zhang, H. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116755 · Cited by 10
Zafari, N., Lotfaliany, M., O'Keefe, G. J., Kishore, K., Torkamani, N., MacIsaac, R. J., Churilov, L. P., & Ekinci, E. I. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa722 · Cited by 11
Azarboo, A., Hosseinkhani, S., Raeini, A. G., Aazami, H., Mohammadi, S. M., Zeidi, S., Razi, F., & Bandarian, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295607 · Cited by 10
Liu, C., Zhong, M., Jin, X., Zhu, J., Cheng, Y., Li, L., Xu, Q., Liu, Q., Ding, H. J., & Zhang, G. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02267-1 · Cited by 9
Role of Extracellular Vesicle-Derived Noncoding RNAs in Diabetic Kidney Disease
Hu, M., Shen, X., & Zhou, L. (2024) · Kidney Diseases · doi:10.1159/000539024 · Cited by 9
Stavas, J., Gerber, D. A., Coca, S. G., Silva, A. L., Johns, A., Jain, D., Bertram, T. A., Ferris, M., & Bakris, G. L. (2022) · American Journal of Nephrology · doi:10.1159/000520231 · Cited by 9
Machado‐Duque, M. E., Gaviria‐Mendoza, A., Valladales‐Restrepo, L. F., Franco, J., Forero, M. D. R., Vizcaya, D., & Machado‐Alba, J. E. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01126-6 · Cited by 13
Roles of Sodium-Glucose Cotransporter 2 of Mesangial Cells in Diabetic Kidney Disease
Wakisaka, M., Nakamura, K., Nakano, T., & Kitazono, T. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab083 · Cited by 9
de Sá, J. R., Rangel², É. B., Bauer, A. C., Betônico, C. D. C. R., Zelmanovitz, T., Moura, A. F. D. S., Silveiro, S. P., Canani, L. H. S., Lauria, M. W., Lamounier, R. N., et al. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-18 · Cited by 14
Aghdam, S. Y., & Mahmoudpour, A. (2016) · International Journal of Nephrology · doi:10.1155/2016/3846573 · Cited by 9
Excess iron accumulation mediated senescence in diabetic kidney injury
Cheng, X., Li, Y., Chen, L., Jiang, C., Peng, S., Yao, P., & Tang, Y. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23683 · Cited by 9
There Is No Impact of Diabetes on the Endothelial Function of Chronic Kidney Disease Patients
Coutinho, M. N., Carvalho, A. B., Dalboni, M. A., Mouro, M. G., Higa, E. M. S., Costa‐Hong, V., Bortolotto, L. A., Figueiredo, R. A. D. O., & Canziani, M. E. F. (2018) · Journal of Diabetes Research · doi:10.1155/2018/7926473 · Cited by 8
Opportunities To Improve Diabetes Care in the Hemodialysis Unit: A Cohort Study in Ontario, Canada
Clemens, K. K., Ouédraogo, A. M., Garg, A. X., Silver, S. A., & Nash, D. M. (2021) · Kidney360 · doi:10.34067/kid.0007082020 · Cited by 9
Lin, S., & Guo, Y. (2021) · Journal of Healthcare Engineering · doi:10.1155/2021/6678454 · Cited by 8
RetractedCarter, D. L. H., & Hoebeke, R. E. (2015) · Applied Nursing Research · doi:10.1016/j.apnr.2015.11.008 · Cited by 8
Could metformin be used in patients with diabetes and advanced chronic kidney disease?
Chowdhury, T. A., Srirathan, D., Abraham, G., Oei, E. L., Fan, S. L., McCafferty, K., & Yaqoob, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12799 · Cited by 7
Bello, B. T., & Amira, C. O. (2017) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.220869 · Cited by 7
Zhao, K., Li, S., Liu, Y., Li, Q., Lin, H., Wu, Z., Seeliger, E., Niendorf, T., Liu, Z., & Wang, W. (2023) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-23-149 · Cited by 7
Association of MMP-9 polymorphisms with diabetic nephropathy risk
Xie, Y., Wang, Z., Chang, L., & Chen, G. (2020) · Medicine · doi:10.1097/md.0000000000022278 · Cited by 7
Forouzanmehr, B., Hedayati, A. H., Gholami, E., Hemmati, M. A., Maleki, M., Butler, A. E., Jamialahmadi, T., Kesharwani, P., Yaribeygi, H., & Sahebkar, A. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111335 · Cited by 6
Li, Z., Cai, Y.-Z., Tang, Z., Zuo, P., Liu, R., & Liu, F. (2018) · Clinical Imaging · doi:10.1016/j.clinimag.2018.04.015 · Cited by 6
Liew, A., Bavanandan, S., Hao, C., Lim, S. K., Prasad, N., Sahay, M., Susantitaphong, P., Roberts, V., Wijewickrama, E. S., Wong, M. G., et al. (2025) · Nephrology · doi:10.1111/nep.70030 · Cited by 6
Mohit, M., Maury, J., Bajpai, J., & Verma, S. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123872 · Cited by 5
Zhou, Y., Chen, K., Du, X., Tang, J., & Shi, B. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01003-3 · Cited by 5
Valverde, S. M., Zepeda‐Tello, R., Castro‐Ríos, A., Toledano‐Toledano, F., Reyes‐Morales, H., Rodriguez-Matías, A., & Duran-Arenas, L. G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19159010 · Cited by 5
Ingwiller, M., Delautre, A., Tivollier, J.-M., Edet, S., Florens, N., Couchoud, C., & Hannedouche, T. P. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100944 · Cited by 6
Jones, J., McBain, H. B., Lamontagne-Godwin, F., Mulligan, K., Haddad, M., Flood, C., Thomas, D., & Simpson, A. (2016) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12311 · Cited by 5
Ahmed, S. B. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201708-1591ed · Cited by 5
Delautre, A., Hannedouche, T. P., Couchoud, C., Guiserix, J., Cerasuolo, D., Chantrel, F., Martzloff, J., Keller, N., Krummel, T., & the REIN registry (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.281 · Cited by 4
Naoxintong capsule delay the progression of diabetic kidney disease: A real-world cohort study
Zhang, Y., Zhang, Y., Yang, C., Duan, Y., Jiang, L., Jin, D., Lian, F., & Tong, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1037564 · Cited by 5
Liu, D., Li, Q., Jia, R., He, W., Zhao, X., Pan, M., Chen, X., Wang, Y., Zhu, Y., Hou, H., et al. (2025) · BMC Nutrition · doi:10.1186/s40795-025-01119-w · Cited by 4
(-)-Gallocatechin Gallate Mitigates Metabolic Syndrome-Associated Diabetic Nephropathy in db/db Mice
Xiao, X., Ge, H., Wang, Y., Wan, X., Li, D., & Xie, Z. (2024) · Foods · doi:10.3390/foods13111755 · Cited by 4
Picroside Ⅱ alleviates renal fibrosis through YY1-dependent transcriptional inhibition of TGFβ1
Zhang, X., Zhang, J., Xu, X., Chen, S., & Gao, F. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100316 · Cited by 4
Zheng, X., Xie, L., Xu, H., Chen, J., Xing, H., Yin, Y., Gao, J., Zhang, S., & Fang, F. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157189 · Cited by 5
Ensuring Patient Safety During the Transition to ESRD
Wagner, L.-A., & Fink, J. C. (2017) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.12.009 · Cited by 4
Ozawa, H., Fukui, K., Komukai, S., Baden, M. Y., Fujita, S., Fujita, Y., Kimura, T., Tokunaga, A., Iwahashi, H., Kozawa, J., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002466 · Cited by 4
Kumar, S. M., Essakky, S., Rajasulochana, S. R., Kar, S. S., Sivanatham, P., Anandraj, J., Parameswaran, S., Soman, B., Rajsekhar, K., & Stanley, A. (2023) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462323002623 · Cited by 4
Sun, M., Yan, G., Sun, S., Li, X., Sun, W., & Wang, Y. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s464615 · Cited by 4
Cao, L., Yu, P., Zhang, L., Yao, Q., Zhou, F., Li, X., & Li, X. (2025) · Nutrition Journal · doi:10.1186/s12937-024-01070-9 · Cited by 4
Bzoma, B., Konopa, J., Chamienia, A. L., & Dębska-Ślizień, A. M. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2018.02.107 · Cited by 4
Diabetes and the Kidney: Sweet Dreams
Novak, J. E., & Yee, J. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2018.01.001 · Cited by 4
Zhu, K., Dong, L., Jinbo, W., Li, D., Chen, M., Jiang, C., & Wang, J. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0098-3 · Cited by 4
Sulaj, A., Kopf, S., von Rauchhaupt, E., Kliemank, E., Brune, M., Κender, Ζ., Bartl, H., Cortizo, F. G., Klepac, K., Han, Z., et al. (2021) · medRxiv · doi:10.1101/2021.12.01.21266958 · Cited by 4
Kamel, W. A., Haghi, M., Khosroshahi, H. T., & Dehghan, G. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10846-z · Cited by 3
Yuan, L., Cai, Q.-J., Yang, Z.-X., Hu, L.-A., Wu, Y., Lu, Y.-C., Liu, Q.-Y., Chen, X., Huang, X., Yu, Y., et al. (2025) · European Journal of Radiology · doi:10.1016/j.ejrad.2025.112578 · Cited by 3
Use of cystatin C to inform metformin eligibility among adult veterans with diabetes
Tuot, D. S., Scherzer, R., Leong, H., Hung, A. M., Grünfeld, C., & Shlipak, M. G. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2015.10.002 · Cited by 3
Zhang, H., Yu, B., Yang, H., Ying, H., Qu, X., Zhu, L., Wang, C., & Ding, J. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s413688 · Cited by 3
Metadata
- Authors
- Molitch, M. E., Adler, A. I., Flyvbjerg, A., Nelson, R. G., So, W.-Y., Wanner, C., Kasiske, B. L., Wheeler, D. C., de Zeeuw, D., & Mogensen, C. E.
- Affiliations
- Northwestern University (US)
- Addenbrooke's Hospital (GB)
- Aarhus University (DK)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Chinese University of Hong Kong (HK)
- Universitätsklinikum Würzburg (DE)
- Hennepin County Medical Center (US)
- University College London (GB)
- Aarhus University Hospital (DK)
- Corresponding author
- Molitch, Mark E.
- ORCID
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 87
- Issue
- 1
- Pages
- 20-30
- ISSN
- 0085-2538 (ISSN-L)
- PMC
- PMC4214898
- OpenAlex
- W2136160292
- Semantic Scholar
- f2af4f6271bd70cd0bbaacb694a7a365a61dea86
- Cited by
- 268
- References
- 135
- Citations by year
- 2026: 18 · 2025: 17 · 2024: 20 · 2023: 17 · 2022: 24 · 2021: 31 · 2020: 34 · 2019: 22 · 2018: 26 · 2017: 23 · 2016: 15 · 2015: 15
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetic nephropathy, chronic kidney disease, type 2 diabetes, end-stage renal disease, albuminuria, estimated glomerular filtration rate, CKD screening, glycemic control, antihypertensive therapy, renin-angiotensin-aldosterone system inhibitors, lipid control, treatment outcomes
- MeSH terms
- Albuminuria, Diabetic Nephropathies, Humans, Hyperglycemia, Hypertension, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
